Related Experiment Video
Updated: Aug 23, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Overexpressed mutant G93A superoxide dismutase protects calcineurin from inactivation
Shipeng Li1, Xutong Wang, Claude B Klee
1Laboratory of Biochemistry, National Cancer Institute, NIH, Bethesda, MD 20892-4255, USA.
Abstract:
Previous studies have claimed that there is a failure of a mutant form of superoxide dismutase (mSOD) to protect the protein phosphatase, calcineurin (CN), against inactivation in the pathogenesis of amyotrophic lateral sclerosis (ALS), as determined in a murine model of ALS resulting from overexpression of mSOD (G93A). In contrast to previous studies, we find that mice overexpressing G93A mSOD have no statistically significant differences in the expression, or activity, of CN. However, CN from G93A mSOD overexpressing mice is significantly more protected against inactivation than non-transgenic mice that do not overexpress SOD. This reduced inactivation of CN is a consequence of increased expression of G93A mSOD. Thus, like wild-type SOD, G93A mSOD protects CN against inactivation.
Insights
Mutant superoxide dismutase (mSOD) in amyotrophic lateral sclerosis (ALS) models protects calcineurin (CN) from inactivation, contrary to previous findings. Increased mSOD expression enhances CN protection, suggesting a protective role for mSOD in ALS pathogenesis.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) pathogenesis involves oxidative stress and protein aggregation.
- Mutant superoxide dismutase (mSOD) is implicated in ALS, with prior studies suggesting its failure to protect calcineurin (CN).
- Calcineurin (CN) is a crucial phosphatase involved in neuronal function and survival.
Purpose of the Study:
- To investigate the protective effect of mutant superoxide dismutase (G93A mSOD) on calcineurin (CN) activity in a murine model of ALS.
- To re-evaluate the role of G93A mSOD in CN inactivation in the context of ALS.
Main Methods:
- Utilized a transgenic mouse model overexpressing G93A mSOD.
- Assessed the expression and activity levels of calcineurin (CN) in G93A mSOD overexpressing mice and non-transgenic controls.
- Quantified the susceptibility of CN to inactivation in both groups.
Main Results:
- No statistically significant differences in CN expression or activity were observed between G93A mSOD overexpressing mice and controls.
- CN from G93A mSOD overexpressing mice exhibited significantly enhanced protection against inactivation compared to controls.
- This increased protection of CN was directly correlated with the elevated expression of G93A mSOD.
Conclusions:
- Contrary to previous claims, G93A mSOD does not fail to protect CN against inactivation in this ALS model.
- Increased expression of G93A mSOD enhances CN protection, indicating a protective role similar to wild-type SOD.
- These findings suggest a potential therapeutic avenue targeting SOD-CN interactions in ALS.
Related Concept Videos
GPCR Desensitization
Abnormal Proliferation
Caspases
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
